| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,590 |
1,498 |
$91K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
909 |
840 |
$91K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,192 |
971 |
$34K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
1,344 |
1,339 |
$12K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
734 |
716 |
$8K |
| 90461 |
|
177 |
176 |
$5K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
53 |
52 |
$4K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
45 |
45 |
$4K |
| 99050 |
|
213 |
201 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
274 |
270 |
$3K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
28 |
28 |
$2K |
| 99051 |
|
150 |
147 |
$2K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
60 |
58 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
104 |
104 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
150 |
148 |
$2K |
| 96127 |
|
172 |
172 |
$2K |
| 99215 |
Prolong outpt/office vis |
15 |
13 |
$2K |
| 0072A |
|
22 |
22 |
$1K |
| 0071A |
|
18 |
18 |
$825.84 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
60 |
58 |
$766.50 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
16 |
16 |
$549.60 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
15 |
13 |
$244.16 |
| 94760 |
|
15 |
13 |
$40.48 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
15 |
13 |
$5.90 |